Chlorotrianisene

08/01/1982 - "The effects of chlorotrianisene (Tace) of kinetics of 3H-testosterone metabolism in patients with carcinoma of the prostate."
10/01/1973 - "Effects of synthetic oral oestrogens in normal men and patients with prostatic carcinoma: lack of gonadotrophin suppression by chlorotrianisene."
05/01/1951 - "Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma."
03/01/1964 - "[CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)]."
11/08/1975 - "A total of 154 patients with carcinoma of the prostate received estrogen therapy with diethylstillbestrol (DES), chlorotrianisene or ethinyl estradiol. "

01/01/1983 - "Previous treatment with chlorotrianisene (TACE) had no detectable effect on prostatic cancer and patients having previously received such treatment had a rate of positive response similar to previously untreated patients (five of five). "
09/14/1955 - "[New advances in hormonal treatment of prostate cancer; the use of chlorotrianisene]."
06/01/1957 - "[Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)]."

07/01/1977 - "Thirty patients with histologically proved metastatic prostatic adenocarcinoma Stage D were treated with a single oral dose of 80 mg. per Kg. hydroxyurea every third day (based on ideal or actual weight, whichever is less) and 12 mg. chlorotrianisene per day. "
09/01/1975 - "There was 13 patinets with histologically metastatic prostatic adenocarcinoma treated with a single oral dose of 80 mg. per kg. hydroxyurea every third day (based on ideal or actual weight, whichever is less) and 12.5 mg. chlorotrianisene per day. "

06/10/2012 - "Among these new associations was the prediction that the abdominal pain side effect of the synthetic oestrogen chlorotrianisene was mediated through its newly discovered inhibition of the enzyme cyclooxygenase-1. "

06/01/1957 - "[Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)]."